Edwards Lifesciences (EW) Cash & Equivalents (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Cash & Equivalents of $2.4 billion for Q1 2026, down 22.13% year-over-year from $3.1 billion in Q1 2025, and down 16.76% quarter-over-quarter from $2.9 billion in Q4 2025.
Edwards Lifesciences (EW) Cash & Equivalents (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Cash & Equivalents history runs 18 years deep, the most recent figure standing at $2.4 billion for Q1 2026.
- In Q1 2026, Cash & Equivalents fell 22.13% year-over-year to $2.4 billion; the TTM figure through Mar 2026 stood at $2.4 billion (down 22.13% YoY), while the FY2025 annual figure was $2.9 billion, down 3.52% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $2.4 billion, down from $2.9 billion in the prior quarter.
- The five-year high for Cash & Equivalents was $3.7 billion in Q3 2024, with the low at $11.7 million in Q4 2023.
- The 5-year median for Cash & Equivalents is $1.4 billion (2023), against an average of $1.9 billion.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents slumped 98.46% in 2023, then surged 25927.35% in 2024.
- Edwards Lifesciences' Cash & Equivalents stood at $761.5 million in 2022, then plunged by 98.46% to $11.7 million in 2023, then soared by 25927.35% to $3.0 billion in 2024, then retreated by 3.52% to $2.9 billion in 2025, then slipped by 16.76% to $2.4 billion in 2026.
- Business Quant data shows EW's Cash & Equivalents at $2.4 billion in Q1 2026, $2.9 billion in Q4 2025, and $2.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.91 Bn |
| Mar 31, 2026 | 2.45 Bn |
| Dec 31, 2025 | 2.94 Bn |
| Sep 30, 2025 | 2.69 Bn |
| Jun 30, 2025 | 3.27 Bn |
| Mar 31, 2025 | 3.14 Bn |
| Dec 31, 2024 | 3.05 Bn |
| Sep 30, 2024 | 3.68 Bn |
| Jun 30, 2024 | 1.64 Bn |
| Mar 31, 2024 | 1.22 Bn |
| Dec 31, 2023 | 11.70 Mn |
| Sep 30, 2023 | 1.41 Bn |
| Jun 30, 2023 | 1.04 Bn |
| Mar 31, 2023 | 872.50 Mn |
| Dec 31, 2022 | 761.50 Mn |
| Sep 30, 2022 | 1.25 Bn |
| Jun 30, 2022 | 1.20 Bn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 862.80 Mn |
| Sep 30, 2021 | 1.51 Bn |